NL-OMON56934尚未招募3 期
Hepatic arterial infusion PUMP chemotherapy combined with systemic therapy versus systemic therapy alone as Induction Therapy for initially unresectable colorectal liver metastases: a randomised controlled trial - PUMP-IT RCT
Antoni van Leeuwenhoek Ziekenhuis0 个研究点目标入组 306 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 3 期
- 状态
- 尚未招募
- 发起方
- 入组人数
- 306
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 99(—)
入选标准
- •Unresectable CRLM (as assessed by National Liver Panel)
- •Resectable primary tumour without indication for neoadjuvant treatment
- •No previous systemic therapy for colorectal cancer
- •No extrahepatic metastases
- •Suitable arterial anatomy for pump placement
- •Written informed consent
排除标准
- •DPD-deficiency
- •MMR-deficiency
研究者
相似试验
尚未招募
2 期
Hepatic arterial infusion PUMP chemotherapy combined with systemIc chemoTherapy for potentially resectable colorectal liver metastasescolorectal carcinoma1001799110019818NL-OMON55263Antoni van Leeuwenhoek Ziekenhuis31
进行中(未招募)
1 期
Regional chemotherapy combined with systemic chemotherapy (PUMP-IT) for potentially resectable colorectal liver metastasesPatients with potentially resectable CRLM without extrahepatic metastases with an indication for systemic therapy as induction or neoadjuvant therapy. Patients have an indication for laparotomyEUCTR2019-003260-44-NLStichting Het Nederlands Kanker Instituut-Antoni van leeuwenhoek Ziekenhuis31
招募中
2 期
Hepatic arterial infusion pump chemotherapy in patients with unresectable intrahepatic cholangiocarcinomaUnresectable intrahepatic cholangiocarcinomaunresectable bileduct cancer in the liver.1001981510019818NL-OMON52590Erasmus MC, Universitair Medisch Centrum Rotterdam50
进行中(未招募)
1 期
Regional chemotherapy for patients with inoperable bileduct cancer in the liver.nresectable intrahepatic cholangiocarcinomaEUCTR2018-004013-41-NLErasmus MC40
招募中
不适用
Hepatic arterial infusion pump chemotherapy in patients with unresectable intrahepatic cholangiocarcinomaNL-OMON23810Erasmus MC, University Medical Center40
